Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients

The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Brain (London, England : 1878) England : 1878), 2004-02, Vol.127 (2), p.439-451
Hauptverfasser: Selcen, Duygu, Ohno, Kinji, Engel, Andrew G.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 451
container_issue 2
container_start_page 439
container_title Brain (London, England : 1878)
container_volume 127
creator Selcen, Duygu
Ohno, Kinji
Engel, Andrew G.
description The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.
doi_str_mv 10.1093/brain/awh052
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_80102627</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>729136601</sourcerecordid><originalsourceid>FETCH-LOGICAL-c517t-212e81adf6246d4e3da91447200c9d7921e43b797a446365ecd7597e918718853</originalsourceid><addsrcrecordid>eNqF0c9rFDEUB_Agit1Wb54lCPbUsXn5OelNi1pxqwgq4iVkM5lu6kyyJjPo_vem3cWCF08h5JOX9_JF6AmQF0A0O11lG-Kp_bUmgt5DC-CSNBSEvI8WhBDZtFqQA3RYyjUhwBmVD9EBcAXQtnSBPl1uUx9WOQyDzXjcpo2d1tsz7IYQg7PDCR5T3qzTkK5uttjGDl_56KfgcJnmLviCQ8SS4Xox-DiVR-hBb4fiH-_XI_TlzevP5xfN8uPbd-cvl40ToKbaIvUt2K6XlMuOe9ZZDZwrSojTndIUPGcrpZXlXDIpvOuU0MpraFVtXbAjdLyru8np5-zLZMZQnK9zRJ_mYloChEqq_gtB10dbBhU--wdepznHOkQ1glOtOanoZIdcTqVk35tNDqPNWwPE3ARibgMxu0Aqf7qvOa9G393hfQIVPN8DW-oH99lGF8qdE5wxuHXNzoUy-d9_z23-YaRiSpiLb98Nf3-5fPUBvhrK_gA8t6H_</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>195429940</pqid></control><display><type>article</type><title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Selcen, Duygu ; Ohno, Kinji ; Engel, Andrew G.</creator><creatorcontrib>Selcen, Duygu ; Ohno, Kinji ; Engel, Andrew G.</creatorcontrib><description>The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.</description><identifier>ISSN: 0006-8950</identifier><identifier>ISSN: 1460-2156</identifier><identifier>EISSN: 1460-2156</identifier><identifier>DOI: 10.1093/brain/awh052</identifier><identifier>PMID: 14711882</identifier><identifier>CODEN: BRAIAK</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adolescent ; Adult ; Age of Onset ; Aged ; Aged, 80 and over ; alpha-Crystallin B Chain - genetics ; Aβ = β‐amyloid protein ; Biological and medical sciences ; CDC = cell division cycle ; Child ; Connectin ; Cytoskeletal Proteins ; desmin ; Desmin - genetics ; Disease Progression ; DNA Mutational Analysis ; Female ; Humans ; KPI = Kunitz protease inhibitor ; LGMD = limb‐girdle muscular dystrophy ; Male ; Medical sciences ; MFM = myofibrillar myopathy ; Microscopy, Electron ; Middle Aged ; MUP = motor unit potential ; Muscle Proteins - genetics ; Muscle Proteins - metabolism ; Muscular Diseases - diagnosis ; Muscular Diseases - genetics ; Muscular Diseases - metabolism ; Muscular Diseases - pathology ; Mutation ; mutation analysis ; myofibrillar myopathy ; Myofibrils - metabolism ; Myofibrils - ultrastructure ; NCAM = neural cell adhesion molecule ; Neural Conduction ; Neurology ; Z‐disk ; αBC = αB‐crystallin ; αB‐crystallin ; βAPP = β‐amyloid precursor protein</subject><ispartof>Brain (London, England : 1878), 2004-02, Vol.127 (2), p.439-451</ispartof><rights>2004 INIST-CNRS</rights><rights>Copyright Oxford University Press(England) Feb 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c517t-212e81adf6246d4e3da91447200c9d7921e43b797a446365ecd7597e918718853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15433182$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/14711882$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Selcen, Duygu</creatorcontrib><creatorcontrib>Ohno, Kinji</creatorcontrib><creatorcontrib>Engel, Andrew G.</creatorcontrib><title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</title><title>Brain (London, England : 1878)</title><addtitle>Brain</addtitle><description>The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age of Onset</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>alpha-Crystallin B Chain - genetics</subject><subject>Aβ = β‐amyloid protein</subject><subject>Biological and medical sciences</subject><subject>CDC = cell division cycle</subject><subject>Child</subject><subject>Connectin</subject><subject>Cytoskeletal Proteins</subject><subject>desmin</subject><subject>Desmin - genetics</subject><subject>Disease Progression</subject><subject>DNA Mutational Analysis</subject><subject>Female</subject><subject>Humans</subject><subject>KPI = Kunitz protease inhibitor</subject><subject>LGMD = limb‐girdle muscular dystrophy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>MFM = myofibrillar myopathy</subject><subject>Microscopy, Electron</subject><subject>Middle Aged</subject><subject>MUP = motor unit potential</subject><subject>Muscle Proteins - genetics</subject><subject>Muscle Proteins - metabolism</subject><subject>Muscular Diseases - diagnosis</subject><subject>Muscular Diseases - genetics</subject><subject>Muscular Diseases - metabolism</subject><subject>Muscular Diseases - pathology</subject><subject>Mutation</subject><subject>mutation analysis</subject><subject>myofibrillar myopathy</subject><subject>Myofibrils - metabolism</subject><subject>Myofibrils - ultrastructure</subject><subject>NCAM = neural cell adhesion molecule</subject><subject>Neural Conduction</subject><subject>Neurology</subject><subject>Z‐disk</subject><subject>αBC = αB‐crystallin</subject><subject>αB‐crystallin</subject><subject>βAPP = β‐amyloid precursor protein</subject><issn>0006-8950</issn><issn>1460-2156</issn><issn>1460-2156</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0c9rFDEUB_Agit1Wb54lCPbUsXn5OelNi1pxqwgq4iVkM5lu6kyyJjPo_vem3cWCF08h5JOX9_JF6AmQF0A0O11lG-Kp_bUmgt5DC-CSNBSEvI8WhBDZtFqQA3RYyjUhwBmVD9EBcAXQtnSBPl1uUx9WOQyDzXjcpo2d1tsz7IYQg7PDCR5T3qzTkK5uttjGDl_56KfgcJnmLviCQ8SS4Xox-DiVR-hBb4fiH-_XI_TlzevP5xfN8uPbd-cvl40ToKbaIvUt2K6XlMuOe9ZZDZwrSojTndIUPGcrpZXlXDIpvOuU0MpraFVtXbAjdLyru8np5-zLZMZQnK9zRJ_mYloChEqq_gtB10dbBhU--wdepznHOkQ1glOtOanoZIdcTqVk35tNDqPNWwPE3ARibgMxu0Aqf7qvOa9G393hfQIVPN8DW-oH99lGF8qdE5wxuHXNzoUy-d9_z23-YaRiSpiLb98Nf3-5fPUBvhrK_gA8t6H_</recordid><startdate>20040201</startdate><enddate>20040201</enddate><creator>Selcen, Duygu</creator><creator>Ohno, Kinji</creator><creator>Engel, Andrew G.</creator><general>Oxford University Press</general><general>Oxford Publishing Limited (England)</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20040201</creationdate><title>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</title><author>Selcen, Duygu ; Ohno, Kinji ; Engel, Andrew G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c517t-212e81adf6246d4e3da91447200c9d7921e43b797a446365ecd7597e918718853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age of Onset</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>alpha-Crystallin B Chain - genetics</topic><topic>Aβ = β‐amyloid protein</topic><topic>Biological and medical sciences</topic><topic>CDC = cell division cycle</topic><topic>Child</topic><topic>Connectin</topic><topic>Cytoskeletal Proteins</topic><topic>desmin</topic><topic>Desmin - genetics</topic><topic>Disease Progression</topic><topic>DNA Mutational Analysis</topic><topic>Female</topic><topic>Humans</topic><topic>KPI = Kunitz protease inhibitor</topic><topic>LGMD = limb‐girdle muscular dystrophy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>MFM = myofibrillar myopathy</topic><topic>Microscopy, Electron</topic><topic>Middle Aged</topic><topic>MUP = motor unit potential</topic><topic>Muscle Proteins - genetics</topic><topic>Muscle Proteins - metabolism</topic><topic>Muscular Diseases - diagnosis</topic><topic>Muscular Diseases - genetics</topic><topic>Muscular Diseases - metabolism</topic><topic>Muscular Diseases - pathology</topic><topic>Mutation</topic><topic>mutation analysis</topic><topic>myofibrillar myopathy</topic><topic>Myofibrils - metabolism</topic><topic>Myofibrils - ultrastructure</topic><topic>NCAM = neural cell adhesion molecule</topic><topic>Neural Conduction</topic><topic>Neurology</topic><topic>Z‐disk</topic><topic>αBC = αB‐crystallin</topic><topic>αB‐crystallin</topic><topic>βAPP = β‐amyloid precursor protein</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Selcen, Duygu</creatorcontrib><creatorcontrib>Ohno, Kinji</creatorcontrib><creatorcontrib>Engel, Andrew G.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Brain (London, England : 1878)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Selcen, Duygu</au><au>Ohno, Kinji</au><au>Engel, Andrew G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients</atitle><jtitle>Brain (London, England : 1878)</jtitle><addtitle>Brain</addtitle><date>2004-02-01</date><risdate>2004</risdate><volume>127</volume><issue>2</issue><spage>439</spage><epage>451</epage><pages>439-451</pages><issn>0006-8950</issn><issn>1460-2156</issn><eissn>1460-2156</eissn><coden>BRAIAK</coden><abstract>The term myofibrillar myopathy (MFM) was proposed in 1996 as a non‐committal term for a pathological pattern of myofibrillar dissolution associated with accumulation of myofibrillar degradation products and ectopic expression of multiple proteins that include desmin, αB‐crystallin (αBC), dystrophin and congophilic amyloid material. Subsequent studies revealed dominant mutations in desmin and αBC in some MFM patients, and clinical differences between kinships. We here review the clinical, structural and genetic features of 63 unrelated patients diagnosed as having MFM at the Mayo Clinic between 1977 and 2003. The age of onset was 54 ± 16 years (mean ± SD). Weakness was both proximal and distal in 77% and proximal only in 13%. Cardiomyopathy was diagnosed in 16%. Electro myography revealed a myopathic pattern associated with abnormal electrical irritability; 13 patients had abnormal nerve conduction studies but four of these had long‐standing diabetes. The abnormal muscle fibres are best identified in trichrome‐stained sections as harbouring amorphous, granular or pleomorphic hyaline structures, and vacuoles containing membranous material. The hyaline structures are strongly congophilic. Semiquantitative analysis in each case indicates that among the abnormal fibres, an average of 90, 75, 75, 70 and 70% abnormally express myotilin, desmin, αBC, dystrophin and β‐amyloid precursor protein, respectively. Therefore, immunostains for these proteins, and especially for myotilin, are useful adjuncts in the diagnosis of MFM. Electron microscopy shows progressive myofibrillar degeneration commencing at the Z‐disk, accumulation of degraded filamentous material and entrapment of dislocated membranous organelles in autophagic vacuoles. In all patients, we searched for mutations in desmin and αBC, as well as in telethonin, a Z‐disk‐associated protein, or in syncoilin, which together with plectin links desmin to the Z‐disk. Two of the 63 patients carry truncation mutations in the C‐terminal domain of αBC, four carry missense mutations in the head or tail region of desmin, and none carries a mutation in syncoilin or telethonin. Thus, MFM is morphologically distinct but genetically heterogeneous. Further advances in defining the molecular causes of MFM will probably come from linkage studies of informative kinships or from systematic search for mutations in proteins participating in the intricate network supporting the Z‐disk.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>14711882</pmid><doi>10.1093/brain/awh052</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-8950
ispartof Brain (London, England : 1878), 2004-02, Vol.127 (2), p.439-451
issn 0006-8950
1460-2156
1460-2156
language eng
recordid cdi_proquest_miscellaneous_80102627
source Oxford University Press Journals All Titles (1996-Current); MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
Age of Onset
Aged
Aged, 80 and over
alpha-Crystallin B Chain - genetics
Aβ = β‐amyloid protein
Biological and medical sciences
CDC = cell division cycle
Child
Connectin
Cytoskeletal Proteins
desmin
Desmin - genetics
Disease Progression
DNA Mutational Analysis
Female
Humans
KPI = Kunitz protease inhibitor
LGMD = limb‐girdle muscular dystrophy
Male
Medical sciences
MFM = myofibrillar myopathy
Microscopy, Electron
Middle Aged
MUP = motor unit potential
Muscle Proteins - genetics
Muscle Proteins - metabolism
Muscular Diseases - diagnosis
Muscular Diseases - genetics
Muscular Diseases - metabolism
Muscular Diseases - pathology
Mutation
mutation analysis
myofibrillar myopathy
Myofibrils - metabolism
Myofibrils - ultrastructure
NCAM = neural cell adhesion molecule
Neural Conduction
Neurology
Z‐disk
αBC = αB‐crystallin
αB‐crystallin
βAPP = β‐amyloid precursor protein
title Myofibrillar myopathy: clinical, morphological and genetic studies in 63 patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T16%3A22%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Myofibrillar%20myopathy:%20clinical,%20morphological%20and%20genetic%20studies%20in%2063%20patients&rft.jtitle=Brain%20(London,%20England%20:%201878)&rft.au=Selcen,%20Duygu&rft.date=2004-02-01&rft.volume=127&rft.issue=2&rft.spage=439&rft.epage=451&rft.pages=439-451&rft.issn=0006-8950&rft.eissn=1460-2156&rft.coden=BRAIAK&rft_id=info:doi/10.1093/brain/awh052&rft_dat=%3Cproquest_cross%3E729136601%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=195429940&rft_id=info:pmid/14711882&rfr_iscdi=true